Skip to main content
Clinical Trials/CTRI/2020/10/028663
CTRI/2020/10/028663
Completed
Phase 2

A clinical study on the comparative assessment in the treatment of Gouty Arthritis (Niqris) with extract and crude form of the Unani polyherbal formulation, a randomized controlled trial.

Ayurvedic and Unani Tibbia College Hospital0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurvedic and Unani Tibbia College Hospital
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 17, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ayurvedic and Unani Tibbia College Hospital

Eligibility Criteria

Inclusion Criteria

  • Patient with clinical features of gouty arthritis, Serum uric acid more than 7 mg/dL, Patient willing to discontinue the drugs taking for the treatment of gouty arthritis, Patient willing to participate in the study and sign the informed consent form

Exclusion Criteria

  • Patient having Gouty arthritis with its complications such as Tophi and renal stones etc, Pregnant and lactating women, Patient receiving Uric acid elevating drugs eg, Pyrazinamide, Thiazide group of diuretics / Aspirin / NSAIDs and Anti\-gouty drugs, Renal insufficiency, Hepatic insufficiency, Cardiovascular disorders, Haemopoietic disorders, Patient suffering from malignancy, taking chemo and radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials